Skip to main content
. 2019 Jun;9(6):1132–1146. doi: 10.21037/qims.2019.05.24

Figure 13.

Figure 13

18F-FDG PET/CT in a 35-year-old woman with multidrug-resistant (MDR) tuberculosis before (A) and after (B) 1 month of anti-tuberculosis treatment. Regression of pulmonary and lymph node pathological foci are observed at the follow-up scan (B). Reproduced with permission from (44). FDG, fluorodeoxyglucose; PET, positron emission tomography; CT, computed tomography.